Last edition
News about " Gene-Therapy Eye-Care Ambitions"
Eli Lilly Acquires Adverum to Embolden Gene-Therapy Eye-Care Ambitions
Eli Lilly has announced that it will acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to USD 261.7 million, signalling a push into the ophthalmology space.
Gene-Therapy Eye-Care Ambitions | 27/10/2025 | By Darshana | 199
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members